Silencing of CD86 in dendritic cells by small interfering RNA regulates cytokine production in T cells from patients with allergic rhinitis in vitro

  • Authors:
    • Rong Sun
    • Yang Yang
    • Zheng Gu
    • Xinye Tang
    • Cheng Zhang
    • Wei Kou
    • Ping Wei
  • View Affiliations

  • Published online on: September 2, 2019     https://doi.org/10.3892/mmr.2019.10638
  • Pages: 3893-3900
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the expression and role of the co‑stimulatory molecule T‑lymphocyte activation antigen CD86 (CD86) in dendritic cells (DCs) from the peripheral blood of patients with allergic rhinitis (AR) compared with those from healthy individuals. It was observed that mature DCs from the peripheral blood of patients with AR expressed high levels of the co‑stimulatory molecule CD86, but not CD80, compared with healthy control subjects. CD86 expression levels in DCs decreased significantly following transfection with siRNA in a lentiviral vector. Furthermore, the level of transforming growth factor‑β1 produced by T cells co‑cultured with DCs was significantly increased in the siRNA group, while interleukin (IL)‑4 and IL‑5 production was significantly decreased. The findings of the present study indicated that CD86 may play a pivotal role in the regulatory T cell/type 2 helper T cell imbalance in allergic inflammation.

References

1 

Pilette C, Jacobson MR, Ratajczak C, Detry B, Banfield G, VanSnick J, Durham SR and Nouri-Aria KT: Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis. Allergy. 68:312–321. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Skrindo I, Ballke C, Gran E, Johansen FE, Baekkevold ES and Jahnsen FL: IL-5 production by resident mucosal allergen-specific T cells in an explant model of allergic rhinitis. Clin Exp Allergy. 45:1296–1304. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H, et al: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 199:1567–1575. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Lee JH, Yu HH, Wang LC, Yang YH, Lin YT and Chiang BL: The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol. 148:53–63. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Sun R, Tang XY and Yang Y: Immune imbalance of regulatory T/type 2 helper cells in the pathogenesis of allergic rhinitis in children. J Laryngol Otol. 130:89–94. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Mellman I and Steinman RM: Dendritic cells: Specialized and regulated antigen processing machines. Cell. 106:255–258. 2001. View Article : Google Scholar : PubMed/NCBI

7 

Lambrecht BN and Hammad H: The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet. 376:835–843. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Lim TS, Goh JK, Mortellaro A, Lim CT, Hämmerling GJ and Ricciardi-Castagnoli P: CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells. PLoS One. 7:e451852012. View Article : Google Scholar : PubMed/NCBI

9 

Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N and Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell. 80:707–718. 1995. View Article : Google Scholar : PubMed/NCBI

10 

Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC and Bluestone JA: Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med. 181:1145–1155. 1995. View Article : Google Scholar : PubMed/NCBI

11 

Vermaelen K and Pauwels R: Accelerated airway dendritic cell maturation, trafficking, and elimination in a mouse model of asthma. Am J Respir Cell Mol Biol. 29:405–409. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Gajewska BU, Swirski FK, Alvarez D, Ritz SA, Goncharova S, Cundall M, Snider DP, Coyle AJ, Gutierrez-Ramos JC, Stämpfli MR and Jordana M: Temporal-spatial analysis of the immune response in a murine model of ovalbumin-induced airways inflammation. Am J Respir Cell Mol Biol. 25:326–334. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Till SJ, Jacobson MR, O'Brien F, Durham SR, KleinJan A, Fokkens WJ, Juliusson S and Löwhagen O: Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy. Allergy. 56:126–131. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P and Fokkens W: Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: Effects of single allergen challenge. J Allergy Clin Immunol. 107:627–633. 2001. View Article : Google Scholar : PubMed/NCBI

15 

KleinJan A, Willart M, van Rijt LS, Braunstahl GJ, Leman K, Jung S, Hoogsteden HC and Lambrecht BN: An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol. 118:1117–1125. 2006. View Article : Google Scholar : PubMed/NCBI

16 

Suzuki M, Zheng X, Zhang X, Zhang ZX, Ichim TE, Sun H, Nakamura Y, Inagaki A, Beduhn M, Shunnar A, et al: A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells. J Allergy Clin Immunol. 125:7372010. View Article : Google Scholar : PubMed/NCBI

17 

Hosoya K, Satoh T, Yamamoto Y, Saeki K, Igawa K, Okano M, Moriya T, Imamura O, Nemoto Y and Yokozeki H: Gene silencing of STAT6 with siRNA ameliorates contact hypersensitivity and allergic rhinitis. Allergy. 66:124–131. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Wang H, Zhang R, Wu J and Hu H: Knockdown of neurokinin-1 receptor expression by small interfering RNA prevents the development of allergic rhinitis in rats. Inflamm Res. 62:903–910. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Zhu XH, Liao B, Liu K and Liu YH: Effect of RNA interference therapy on the mice eosinophils CCR3 gene and granule protein in the murine model of allergic rhinitis. Asian Pac J Trop Med. 7:226–230. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Cho Y, Jang Y, Yang YD, Lee CH, Lee Y and Oh U: TRPM8 mediates cold and menthol allergies associated with mast cell activation. Cell Calcium. 48:202–208. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Srivastava S, Cai X, Li Z, Sun Y and Skolnik EY: Phosphatidylinositol-3-kinase C2β and TRIM27 function to positively and negatively regulate IgE receptor activation of mast cells. Mol Cell Biol. 32:3132–3139. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Wang Y, Lin L and Zheng C: Downregulation of Orai1 expression in the airway alleviates murine allergic rhinitis. Exp Mol Med. 44:177–190. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, et al: Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 63 (Suppl 86):S8–S160. 2008. View Article : Google Scholar

24 

Wong CK, Lun SW, Ko FW, Ip WK, Hui DS and Lam CW: Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clin Exp Immunol. 141:122–129. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Asai-Tajiri Y, Matsumoto K, Fukuyama S, Kan-O K, Nakano T, Tonai K, Ohno T, Azuma M, Inoue H and Nakanishi Y: Small interfering RNA against CD86 during allergen challenge blocks experimental allergic asthma. Respir Res. 15:1322014. View Article : Google Scholar : PubMed/NCBI

26 

Ritprajak P, Hashiguchi M and Azuma M: Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells. Mol Ther. 16:1323–1330. 2008. View Article : Google Scholar : PubMed/NCBI

27 

Nakajima A, Watanabe N, Yoshino S, Yagita H, Okumura K and Azuma M: Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int Immunol. 9:637–644. 1997. View Article : Google Scholar : PubMed/NCBI

28 

Tsuyuki S, Tsuyuki J, Einsle K, Kopf M and Coyle AJ: Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med. 185:1671–1679. 1997. View Article : Google Scholar : PubMed/NCBI

29 

Huh JC, Strickland DH, Jahnsen FL, Turner DJ, Thomas JA, Napoli S, Tobagus I, Stumbles PA, Sly PD and Holt PG: Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J Exp Med. 198:19–30. 2003. View Article : Google Scholar : PubMed/NCBI

30 

Crosby JR, Guha M, Tung D, Miller DA, Bender B, Condon TP, York-DeFalco C, Geary RS, Monia BP, Karras JG and Gregory SA: Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice. J Pharmacol Exp Ther. 321:938–946. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature. 392:245–252. 1998. View Article : Google Scholar : PubMed/NCBI

32 

Lutz MB and Schuler G: Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends Immunol. 23:445–449. 2002. View Article : Google Scholar : PubMed/NCBI

33 

You S, Leforban B, Garcia C, Bach JF, Bluestone JA and Chatenoud L: Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc Natl Acad Sci USA. 104:6335–6340. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2019
Volume 20 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Sun, R., Yang, Y., Gu, Z., Tang, X., Zhang, C., Kou, W., & Wei, P. (2019). Silencing of CD86 in dendritic cells by small interfering RNA regulates cytokine production in T cells from patients with allergic rhinitis in vitro. Molecular Medicine Reports, 20, 3893-3900. https://doi.org/10.3892/mmr.2019.10638
MLA
Sun, R., Yang, Y., Gu, Z., Tang, X., Zhang, C., Kou, W., Wei, P."Silencing of CD86 in dendritic cells by small interfering RNA regulates cytokine production in T cells from patients with allergic rhinitis in vitro". Molecular Medicine Reports 20.4 (2019): 3893-3900.
Chicago
Sun, R., Yang, Y., Gu, Z., Tang, X., Zhang, C., Kou, W., Wei, P."Silencing of CD86 in dendritic cells by small interfering RNA regulates cytokine production in T cells from patients with allergic rhinitis in vitro". Molecular Medicine Reports 20, no. 4 (2019): 3893-3900. https://doi.org/10.3892/mmr.2019.10638